Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk, Squamous Cell Cancer of the Head and NeckCIRB: Adult CIRB - Late Phase EmphasisLead Group: RTOGStatus: Temporarily Closed to AccrualReview Status: Available to Open
